Work

Hesperadin, an aurora B kinase inhibitor, synergizes with chidamide to suppress T-cell acute lymphoblastic leukemia by targeting c-MYC

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6828

Authors: Boxiao Chen, Zhaoxing Wu, Luyu Yang, Yang Xu

Institutions: Second Affiliated Hospital of Zhejiang University, Zhejiang University

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417004273

Cites:

Cited by: 1

Related to: